Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fallopian Tube Neoplasms × cobimetinib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Brain Neoplasms 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Solid Tumors 1 Solid Tumor 1 Sarcoma, Clear Cell 1 Neoplasms, Unknown Primary 1 Microsatellite Unstable Colorectal Cancer 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Inflammatory Breast Neoplasms 1 Histiocytosis, Sinus 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Histiocytic Disorders, Malignant 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Carboplatin 50 Paclitaxel 44 Bevacizumab 32 Gemcitabine 18 pembrolizumab 15 Taxes 12 olaparib 11 Cisplatin 11 Immunoglobulin G 10 Disulfides 10 Topotecan 9 niraparib 8 Cyclophosphamide 7 Specimen Handling 6 Biopsy 6 mirvetuximab soravtansine 5 Nivolumab 5 Letrozole 5 Drug Therapy 5 Docetaxel 5 Cytoreduction Surgical Procedures 5 Albumin-Bound Paclitaxel 5 rucaparib 4 oregovomab 4 liposomal doxorubicin 4 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4 Hyperthermic Intraperitoneal Chemotherapy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03363867 2023-08-07

BEACON

Peter MacCallum Cancer Centre, Australia

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡